Loading…
← CockpitCompetitor Analysis › 4369.T Tri Chemical Laboratories Inc.Open in the cockpit ↗

Tri Chemical Laboratories Inc.4369.TCompetitor analysis, valuation and peers

Japan · JPY·Industrials›Industrial Conglomerates
Momentum laggard 8
Mkt cap
$511M
US dollars, full cap
Free float
80%
of shares outstanding
$/day
$9.90M
20-day average traded
Fwd P/E
12.3×
forward earnings
ROIC−WACC
-1.1 pp
WACC 14.4%
Hurdle
-0 pp
Req g minus delivered
Next earnings
24 days
30 Nov 2026
Close · JPY¥2,480
1D-6.2%
1W-21.9%
1M-27.5%
3M-23.8%
6M-22.5%
YTD-8.5%
1Y-13.9%
ATR %7.6%
52w lowhigh44.3% off high

What Tri Chemical Laboratories does

Employees: 313

Tri Chemical Laboratories at a glance

Size Tri Chemical Laboratories (4369.T) is a Japan Industrials company (Industrial Conglomerates) with a market value of $511M, the 1056th largest of 1,379 Japan companies the cockpit tracks. Shares closed at ¥2,480 on 6 Nov 2026.

Performance Over six months the shares fell 22.5%, against -14.6% for the median peer and +1.8% for the Japan market (cap-weighted) — 4th lowest of 9 in its peer set.

Growth Revenue grew 12.5% over the last twelve months (peer median +10.0%); the operating margin is 25.0% (peer median 4.0%).

Valuation It trades at 12.3× forward earnings against a peer median of 10.3× (3rd most expensive of 7).

Price implies For today's price to make sense, revenue must grow about 19% a year for seven years (Req g). Recent delivered growth is +19%, so the hurdle is -0 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 1.1 points below its cost of capital (14.4% WACC).

Next results Next results expected around 30 Nov 2026 (exchange calendar; dates can move).

Relative performance

8010012011 May 202611 Aug 20266 Nov 2026Peer median 864369.T 80
Six months, rebased to 100: Tri Chemical Laboratories against the median of its 8 peers (local-currency closes).

Tri Chemical Laboratories financials

Reported figures in JPY; fiscal year ends 2026-01-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue¥26.2B¥23.9B¥18.9B¥11.2B¥13.8B
Revenue growth—+26%+68%-19%—
Gross profit¥9.63B¥8.94B¥7.95B¥4.02B¥5.51B
EBITDA¥8.84B¥7.82B¥6.63B¥3.25B¥4.71B
Net income¥6.11B¥5.52B¥4.96B¥2.47B¥4.83B
Free cash flow¥198M-¥2.49B¥606M¥1.23B¥4.86B
Capital expenditure¥5.76B¥6.33B¥3.08B¥1.78B¥1.56B
Total debt¥6.05B¥4.13B¥1.78B¥2.40B¥3.24B

Quarterly statements and history in the cockpit →

Tri Chemical Laboratories competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%0%+50%+100%+150%-60%-40%-20%0%GSJ3318301335301011642532726027674369.T6-month return →1-month return →
Up and to the right = strong over both horizons. Tri Chemical Laboratories is the large dot.

Fundamentals: revenue growth against valuation

0%+20%+40%+60%25×50×75×GSJ301335642532726027674369.TRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Tri Chemical Laboratories is the large dot.

Capital: growth delivered against growth the price implies

0%+20%0%20%30133564253272602767DCMSHRIRAM4369.TGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Tri Chemical Laboratories is the large dot.

Tri Chemical Laboratories competitors and peer comparison

How Tri Chemical Laboratories compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Tri Chemical Laboratories against its 8 peers (data as of 6 Nov 2026)
Measure4369.TPeer medianRank in peer set
1-month return-27.5%-4.3%2nd lowest of 9
6-month return-22.5%-14.6%4th lowest of 9
Distance from 52-week high-44.3%-30.6%3rd lowest of 9
Revenue growth (TTM)+12.5%+10.0%3rd highest of 9
Operating margin25.0%4.0%highest of 9
Forward P/E12.3×10.3×3rd most expensive of 7
Growth the price implies (Req g, 7 yrs)19.4%15.1%most demanding of 6
Growth delivered (Del g)+19.5%+15.7%3rd highest of 6
Hurdle (Req g minus delivered)-0.1 pp-2.7 pp3rd most demanding of 6
ROIC minus cost of capital-1.1 pp-3.6 pp3rd highest of 8
EV / EBITDA8.7×9.8×2nd cheapest of 5
Net debt / EBITDA-0.5×-0.1×4th least indebted of 7

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Tri Chemical Laboratories 4369.TJapan$511M-22%+12%25%12.3×19.4%+19.5%
Grupo Empresarial San Jose GSJ.MCSpain$517M-14%+11%4%10.6×n/an/a
China Boton 3318.HKHong Kong$435M+163%+11%-5%n/an/an/a
Hangzhou Tianyuan Pet Products 301335.SZChina$415M-15%+4%2%88.6×13.0%+15.7%
Guangzhou Wahlap Technology 301011.SZChina$325M-30%-18%-8%n/an/an/a
Universal Entertainment 6425.TJapan$324M-10%+9%4%9.4×15.1%+6.2%
RF Materials 327260.KSSouth Korea$292M-51%+57%18%29.5×16.7%+28.6%
Tsuburaya Fields 2767.TJapan$963M+72%-5%10%10.1×-10.3%+35.0%
DCM Shriram DCMSHRIRAM.NSIndia$1.47B-29%+14%7%9.2×16.6%+10.7%

Questions

Which companies are Tri Chemical Laboratories's closest peers?
The cockpit's peer set: Grupo Empresarial San Jose (GSJ.MC), China Boton (3318.HK), Hangzhou Tianyuan Pet Products (301335.SZ), Guangzhou Wahlap Technology (301011.SZ), Universal Entertainment (6425.T), RF Materials (327260.KS), Tsuburaya Fields (2767.T), DCM Shriram (DCMSHRIRAM.NS).
Is Tri Chemical Laboratories expensive compared with its peers?
On forward p/e it trades at 12.3× against a peer median of 10.3×, 3rd most expensive of 7 in its peer set. For today's price to make sense, revenue must grow about 19% a year for seven years (Req g). Recent delivered growth is +19%, so the hurdle is -0 pp: the price already allows for a slowdown.
How has Tri Chemical Laboratories stock performed?
Over six months to 6 Nov 2026 the shares returned -22.5% against -14.6% for the median peer; over one year -13.9%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.